Allianz Asset Management GmbH Has $4.39 Million Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

Allianz Asset Management GmbH grew its position in Nu Skin Enterprises, Inc. (NYSE:NUSFree Report) by 45.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 226,069 shares of the company’s stock after purchasing an additional 70,578 shares during the period. Allianz Asset Management GmbH owned about 0.46% of Nu Skin Enterprises worth $4,390,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Invesco Ltd. lifted its position in Nu Skin Enterprises by 91.8% during the 3rd quarter. Invesco Ltd. now owns 1,694,112 shares of the company’s stock worth $35,932,000 after buying an additional 810,778 shares in the last quarter. Norges Bank acquired a new position in Nu Skin Enterprises during the 4th quarter worth about $8,930,000. Federated Hermes Inc. lifted its position in Nu Skin Enterprises by 29,649.3% during the 4th quarter. Federated Hermes Inc. now owns 330,812 shares of the company’s stock worth $6,424,000 after buying an additional 329,700 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in Nu Skin Enterprises by 17.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock worth $22,482,000 after buying an additional 173,193 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in Nu Skin Enterprises by 1,015.1% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 186,417 shares of the company’s stock worth $3,954,000 after buying an additional 169,699 shares in the last quarter. Institutional investors and hedge funds own 82.84% of the company’s stock.

Nu Skin Enterprises Price Performance

Shares of NYSE:NUS opened at $13.47 on Thursday. Nu Skin Enterprises, Inc. has a 1-year low of $11.73 and a 1-year high of $35.66. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.09 and a quick ratio of 1.24. The business has a 50-day moving average price of $12.89 and a two-hundred day moving average price of $15.25.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last announced its quarterly earnings results on Wednesday, May 8th. The company reported $0.09 EPS for the quarter, beating analysts’ consensus estimates of $0.05 by $0.04. The company had revenue of $417.31 million during the quarter, compared to analysts’ expectations of $426.55 million. Nu Skin Enterprises had a positive return on equity of 9.28% and a negative net margin of 0.17%. Nu Skin Enterprises’s revenue was down 13.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.37 EPS. On average, equities research analysts expect that Nu Skin Enterprises, Inc. will post 1.1 earnings per share for the current year.

Nu Skin Enterprises Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Friday, May 31st will be paid a $0.06 dividend. The ex-dividend date is Friday, May 31st. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.78%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently -399.93%.

Insider Activity

In other news, Director Andrew D. Lipman sold 2,000 shares of the company’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $13.33, for a total value of $26,660.00. Following the completion of the sale, the director now directly owns 23,225 shares of the company’s stock, valued at approximately $309,589.25. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold a total of 7,693 shares of company stock valued at $96,330 in the last ninety days. 1.70% of the stock is owned by insiders.

Analyst Ratings Changes

NUS has been the topic of several research reports. DA Davidson reduced their price target on shares of Nu Skin Enterprises from $15.50 to $12.50 and set a “neutral” rating on the stock in a research report on Thursday, May 9th. StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Saturday, February 24th. Four equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, Nu Skin Enterprises presently has an average rating of “Hold” and a consensus price target of $20.83.

Read Our Latest Report on Nu Skin Enterprises

Nu Skin Enterprises Company Profile

(Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Stories

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUSFree Report).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.